Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-02-06Clinical Trial Update: Enhancing Antiepileptic Drug Adherence [NA]
A completed clinical trial conducted by Qazvin University of Medical Sciences evaluating strategies to improve adherence to antiepileptic dr…
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Pharmacodynamics of Nasal and Buccal Midazolam Using EEG [Phase 1]
A Phase 1 study evaluated the pharmacodynamics of nasal and buccal midazolam using EEG in epilepsy. The study status is TERMINATED.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Pilot Study to Evaluate MR-guided Laser Ablation of Focal Lesions in Patients With Medically Refractory Partial Epilepsy [Phase 1]
This clinical trial update reports the completion of a Phase 1 pilot study evaluating MR-guided laser ablation of focal lesions in patients …
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Effect of Repeated Administration of Eslicarbazepine Acetate on the Pharmacokinetics of Simvastatin in Healthy Subjects [Phase 1]
Phase 1 trial evaluating whether repeated administration of eslicarbazepine acetate affects the pharmacokinetics of simvastatin in healthy s…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Comparative Bioavailability Study of Two Different Sources of Eslicarbazepine Acetate [Phase 1]
This document reports a Phase 1 comparative bioavailability study of two sources of eslicarbazepine acetate conducted by Bial - Portela C S.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 [Phase 1]
An open-label Phase 1 pharmacokinetic study of BIA 2-093 in epilepsy has completed, and its results have been posted.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers [Phase 1]
A Phase 1 trial assessing tolerability and pharmacokinetics of a single 900 mg oral dose of BIA 2-093 with oxcarbazepine in healthy voluntee…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Food Effect and Dosage Form Proportionality Study of Eslicarbazepine Acetate [Phase 1]
Phase 1 study evaluating the food effect and dosage form proportionality of eslicarbazepine acetate has been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine [Phase 1]
Phase 1 pharmacokinetic interaction study evaluating eslicarbazepine acetate with carbamazepine in epilepsy; results have been posted after …
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093 [Phase 1]
A Phase 1 double-blind, randomized, placebo-controlled, rising multiple-dose study assessed safety, tolerability, steady-state pharmacokinet…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Single Centre, Phase I, Double-blind, Randomised, Placebo-controlled Study to Investigate the Safety, Tolerability, Pharmacokinetic Profile and Effects on EEG of Single Rising Oral Doses of BIA 2-093 [Phase 1]
Phase I trial evaluating safety, tolerability, pharmacokinetics, and EEG effects of single rising oral doses of BIA 2-093 in epilepsy; study…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers [Phase 1]
Phase 1 study evaluating the steady-state pharmacokinetics of the candidate BIA 2-093 and oxcarbazepine in healthy volunteers to inform dosi…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093 [Phase 1]
Phase 1 trial evaluating single-dose pharmacokinetics and relative bioavailability of an oral suspension and two tablet formulations of BIA …
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites [Phase 1]
A Phase 1 pharmacokinetic study assessing single-dose and steady-state exposure of BIA 2-093 and its metabolites in the context of epilepsy.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: The Effect of BIA 2-093 on the Steady-state Pharmacokinetics of Digoxin [Phase 1]
Phase 1 study assessing whether BIA 2-093 alters the steady-state pharmacokinetics of digoxin.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 [Phase 1]
Open-label Phase 1 single-dose pharmacokinetics study of BIA 2-093 in epilepsy, completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Intraoral 30% Glucose Effect In Newborns [Phase 3]
A Phase 3 trial evaluating intraoral 30% glucose in newborns has completed, investigating effects in epilepsy and hydrocephaly.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers [Phase 1]
Phase 1 study evaluating tolerability and pharmacokinetics of single and multiple high-dose regimens of the epilepsy drug candidate BIA 2-09…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization [Phase 1]
Phase 1 trial evaluating whether eslicarbazepine acetate affects cardiac repolarization in epilepsy patients; the study completed and result…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate [Phase 1]
Open-label Phase 1 trial evaluating the drug interaction between eslicarbazepine acetate and topiramate in epilepsy; the study has completed…
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of sequentially escalating doses of eslicarbazepine acetate in healthy adult volunteers.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin. [Phase 1]
An open-label Phase 1 trial assessed the drug interaction between eslicarbazepine acetate and phenytoin in epilepsy, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093 [Phase 1]
This Phase 1 trial evaluated tolerability and how food affects the pharmacokinetics of a single 800 mg oral dose of BIA 2-093 in epilepsy.
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function [Phase 1]
Phase 1 study investigating the effects of eslicarbazepine acetate (BIA 2-093) on cognition and psychomotor function in epilepsy patients; r…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation [Phase 1]
Phase 1 single-dose crossover study compared the bioavailability of eslicarbazepine acetate to a to-be-marketed formulation in epilepsy; res…